Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07441148 · ClinicalTrials.gov registry record · NA
Digital vs. Parent Modeled Toothbrushing
A NA study of Plaque Reduction, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 112
- Enrollment target
- 1
- Study location
NCT07441148: Recruiting NA study of Plaque Reduction, sponsored by University of Southern California.
NCT07441148 is a NA study of Plaque Reduction that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 112 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07441148, a NA study of Plaque Reduction, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective randomized controlled trial will aim to evaluate the effectiveness of two methods of delivering oral hygiene instruction to children aged 3 - 6 years: parent-modeled toothbrushing (control) and the MoodBrush digital application (experimental). The primary endpoint is the change in plaque index scores before and after brushing, measured on 12 tooth surfaces using the Silness and Loe Plaque Index. The study rationale is based in the need to identify efficient and engaging strategies to improve pediatric oral hygiene. The expected outcome is that both groups will demonstrate significant reductions in plaque scores, with children using MoodBrush achieving similar, if not greater improvements in plaque index scores. Follow-up includes an immediate post-brushing assessment at the dental visit, with intrarater reliability checks to ensure measurement consistency. Statistical analyses will include paired t-tests to evaluate pre-post changes within groups and two-sample t-tests to compare differences between groups, with significance set at p \< 0.05. A sample size of 112 participants provides 80% power to detect a mean difference of 0.30 in plaque index score reduction.
Primary Outcome
The primary outcome of this study is the change in plaque index scores before and after toothbrushing using two different methods. Through the measurements of 12 different tooth surfaces as per the Silness and Loe Plaque Index, the plaque scores recorded will be used to assess the immediate effectiveness of each anticipatory guidance method, both parent modeled instruction versus the MoodBrush digital application. Silness and Loe Plaque Index: dental scoring system that measures the thickness o
Conditions Studied
Interventions
- DEVICE MoodBrush Digital Application
Study Locations (1)
California
- University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT07441148 shows while recruiting
NCT07441148 is an interventional study that assigns participants to a tested intervention. The registered 112 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Plaque Reduction appearing as the primary indexed condition, and to 1 intervention - of which MoodBrush Digital Application is the first listed.
NCT07441148 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07441148 about?
NCT07441148 is a clinical study titled "Digital vs. Parent Modeled Toothbrushing". This prospective randomized controlled trial will aim to evaluate the effectiveness of two methods of delivering oral hygiene instruction to children aged 3 - 6 years: parent-modeled toothbrushing (control) and the MoodBrush digital application (experimental). The primary endpoint is the change in p...
What is the current status of trial NCT07441148?
This trial is currently recruiting. It is a NA study. The enrollment target is 112 participants. The study started on 2026-01-05. Estimated completion is 2027-06-30.
What conditions does trial NCT07441148 study?
This clinical trial studies the following conditions: Plaque Reduction.
What interventions are being tested in trial NCT07441148?
The interventions under investigation include: MoodBrush Digital Application (DEVICE).
Who is sponsoring clinical trial NCT07441148?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07441148 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07441148's enrollment target sits among peer trials
112 813th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04511013 · 112 participants · Phase 2
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- NCT04551560 · 112 participants · NA
Stress and Congestive Heart Failure
- NCT04872166 · 112 participants · Phase 1
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer
- NCT05024773 · 112 participants · Phase 3
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI